Article
Risk Factors And Treatment Outcome Of Children With HCV Infection.
Journal of Ayub Medical College, Abbottabad : JAMC - 1 Jan 2000
Khosa Ghazi, Aziz Muhammad Tariq, Suleman Hassan, Hussain Ibrar, Abu-Talib Muhammad, Joya Saima Jabeen
Abstract excerpt
BACKGROUND: Combination of pegylated interferon α-2a or α-2b has been considered to be the standard for treating HCV infection among children. Many new agents inhibiting HCV during various steps while replicating is under study around the world. This study was aimed to note the efficacy of sofosbuvir and ribavirin among children having HCV infection. METHODS: This was an open label experimental trail done at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
